HKBU lnstitute for Research and Continuing Education, Shenzhen, China; Institute of Integrated Bioinformedicine and Translational Sciences, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, China.
HKBU lnstitute for Research and Continuing Education, Shenzhen, China; Institute of Integrated Bioinformedicine and Translational Sciences, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, China.
Life Sci. 2023 Oct 1;330:121919. doi: 10.1016/j.lfs.2023.121919. Epub 2023 Jul 6.
Bile acids (BAs) function as detergents promoting nutrient absorption and as hormones regulating nutrient metabolism. Most BAs are key regulatory factors of physiological activities, which are involved in the regulation of glucose, lipid, and drug metabolisms. Hepatic and intestinal diseases have close connections with the systemic cycling disorders of BAs. The abnormal in BA absorption came up with overmuch BAs could be involved in the pathophysiology of liver and bowel and metabolic disorders such as fatty liver diseases and inflammatory bowel diseases. The primary BAs (PBAs), which are synthesized in the liver, can be transformed into the secondary BAs (SBAs) by gut microbiota. The transformation processes are tightly associated with the gut microbiome and the host endogenous metabolism. The BA biosynthesis gene cluster bile-acid-inducible operon is essential for modulating BA pool, gut microbiome composition, and the onset of intestinal inflammation. This forms a bidirectional interaction between the host and its gut symbiotic ecosystem. The subtle changes in the composition and abundance of BAs perturb the host physiological and metabolic activity. Therefore, maintaining the homeostasis of BAs pool contributes to the balance of the body's physiological and metabolic system. Our review aims to dissect the molecular mechanisms underlying the BAs homeostasis, assess the key factors sustaining the homeostasis and the role of BA acting on host diseases. By linking the BAs metabolic disorders and their associated diseases, we illustrate the effects of BAs homeostasis on health and potential clinical interventions can be taken under the latest research findings.
胆汁酸(BAs)作为促进营养吸收的清洁剂和调节营养代谢的激素发挥作用。大多数 BAs 是生理活动的关键调节因子,参与调节葡萄糖、脂质和药物代谢。肝脏和肠道疾病与 BAs 的全身循环紊乱密切相关。胆汁酸吸收异常导致过多的 BAs 可能参与肝脏和肠道的病理生理学以及代谢紊乱,如脂肪肝和炎症性肠病。初级胆汁酸(PBAs)在肝脏中合成,可以被肠道微生物群转化为次级胆汁酸(SBAs)。转化过程与肠道微生物群和宿主内源性代谢紧密相关。胆汁酸诱导操纵子是调节胆汁酸库、肠道微生物群组成和肠道炎症发生的必需基因簇。这形成了宿主与其肠道共生生态系统之间的双向相互作用。BAs 组成和丰度的细微变化会扰乱宿主的生理和代谢活动。因此,维持 BAs 库的动态平衡有助于维持身体的生理和代谢系统的平衡。我们的综述旨在剖析 BAs 动态平衡的分子机制,评估维持平衡的关键因素以及 BAs 对宿主疾病的作用。通过将 BAs 代谢紊乱及其相关疾病联系起来,我们说明了 BAs 动态平衡对健康的影响,并根据最新的研究结果可以采取潜在的临床干预措施。